Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

بواسطة Kluth, Martina, Ahrary, Ramin, Hube-Magg, Claudia, Ahmed, Malik, Volta, Heinke, Schwemin, Catina, Steurer, Stefan, Wittmer, Corinna, Wilczak, Waldemar, Burandt, Eike, Krech, Till, Adam, Meike, Michl, Uwe, Heinzer, Hans, Salomon, Georg, Graefen, Markus, Koop, Christina, Minner, Sarah, Simon, Ronald, Sauter, Guido, Schlomm, Thorsten
الحاوية / القاعدة Oncotarget (2015)

Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

بواسطة Kluth, Martina, Ahrary, Ramin, Hube-Magg, Claudia, Ahmed, Malik, Volta, Heinke, Schwemin, Catina, Steurer, Stefan, Wittmer, Corinna, Wilczak, Waldemar, Burandt, Eike, Krech, Till, Adam, Meike, Michl, Uwe, Heinzer, Hans, Salomon, Georg, Graefen, Markus, Koop, Christina, Minner, Sarah, Simon, Ronald, Sauter, Guido, Schlomm, Thorsten
الحاوية / القاعدة Oncotarget (2017)

Deletion of 3p13 is a late event linked to progression of TMPRSS2:ERG fusion prostate cancer

بواسطة Kluth, Martina, Volta, Heinke, Hussein, Mohammad, Taskin, Billurvan, Frogh, Sohall, Möller-Koop, Christina, Büscheck, Franziska, Jacobsen, Frank, Tsourlakis, Maria Christina, Lübke, Andreas M, Hinsch, Andrea, Clauditz, Till, Graefen, Markus, Heinzer, Hans, Huland, Hartwig, Minner, Sarah, Sauter, Guido, Wilczak, Waldemar, Schlomm, Thorsten, Simon, Ronald
الحاوية / القاعدة Cancer Manag Res (2018)